Connor, Clark & Lunn Investment Management (CC&L)’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.5M | Buy |
224,721
+48,779
| +28% | +$5.09M | 0.08% | 213 |
|
|
2025
Q1 | $20.5M | Buy |
175,942
+102,445
| +139% | +$11.9M | 0.09% | 186 |
|
|
2024
Q4 | $6.22M | Buy |
+73,497
| New | +$6.22M | 0.03% | 429 |
|
|
2024
Q1 | – | Sell |
-14,339
| Closed | -$1.14M | – | 1521 |
|
|
2023
Q4 | $1.14M | Buy |
+14,339
| New | +$1.14M | 0.01% | 825 |
|
|
2022
Q2 | – | Sell |
-9,195
| Closed | -$381K | – | 1038 |
|
|
2022
Q1 | $381K | Buy |
+9,195
| New | +$381K | ﹤0.01% | 831 |
|